8-K: Armata Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting

Armata Pharmaceuticals announces the date for its 2025 annual meeting of stockholders and related deadlines for stockholder proposals and director nominations.

Summary

• Armata Pharmaceuticals has scheduled its 2025 annual meeting of stockholders for June 12, 2025.
• The meeting will take place at 8:30 a.m. Pacific Time at the company's principal executive offices in Los Angeles, California.
• Stockholders of record as of April 17, 2025, are eligible to vote at the meeting.
• The deadline for submitting stockholder proposals and director nominations is 5:00 p.m. Eastern Time on April 13, 2025.
• Submissions must be in writing and received by the Corporate Secretary at the company's principal executive offices by the deadline.
• Proposals and nominations must comply with the company's Amended and Restated Bylaws.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of a routine corporate event, so the sentiment is neither positive nor negative.

Future Outlook

The document does not contain any specific forward-looking statements regarding financial performance or business strategy beyond the announcement of the annual meeting.

Industry Context

This announcement is a routine corporate governance matter for a publicly traded company. Setting the date and outlining the procedures for the annual meeting are standard practices.

Stakeholder Impact

• Shareholders are informed about the date of the annual meeting and their rights to participate.
• The announcement allows shareholders to submit proposals and nominate directors.

Next Steps

• Stockholders to submit proposals and nominations by the specified deadline.
• Armata Pharmaceuticals to prepare and distribute the proxy statement for the Annual Meeting.
• Armata Pharmaceuticals to hold the Annual Meeting on June 12, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Armata Pharmaceuticals, Proposals, Nominations, Corporate Governance